WHERE

ARE WE

NEW CENTERS PLAN

Eleven qualified “Research Centers” in three states, skilled to manage all phases of the Clinical Trials processes (Preclinical, and Clinical of 1, 2, 3 and 4 phases) and support all the Healthcare Industry – pharmaceutical research industry, hospitals and clinics, physicians and healthcare professionals, scientists and researchers, schools and universities, Patients Advocacy Groups (PAGs), associations, autarchies and government (CEP, Conep, Anvisa, EMEA and FDA). Learn about our expansion plan for our research centers: